Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2004;35:853-858
Published online before print March 4, 2004, doi: 10.1161/01.STR.0000120730.54282.A0
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/4/853    most recent
01.STR.0000120730.54282.A0v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hussain, M. B.
Right arrow Articles by Singer, D. R.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hussain, M. B.
Right arrow Articles by Singer, D. R.J.
Related Collections
Right arrow Clinical genetics
Right arrow ACE/Angiotension receptors
Right arrow Acute Stroke Syndromes
Right arrow Genetics of Stroke
Right arrow Other Vascular biology

(Stroke. 2004;35:853.)
© 2004 American Heart Association, Inc.


Original Contributions

Abnormal Vasoconstrictor Responses to Angiotensin II and Noradrenaline in Isolated Small Arteries From Patients With Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)

Monira B. Hussain, PhD; Sumeet Singhal, BM, BCh, BSc; Hugh S. Markus, BMBCh, MD, FRCP Donald R.J. Singer, BMedBiol, MD, FRCP

From Pharmacology and Clinical Pharmacology (M.B.H.) and Clinical Neuroscience (S.S., H.S.M.), St George’s Hospital Medical School, London, and Clinical Sciences, Warwick Medical School (D.R.J.S.), University of Warwick, Coventry, UK.

Correspondence to Donald R.J. Singer, Professor of Clinical Pharmacology, Clinical Sciences, Warwick Medical School (LWMS), University of Warwick, Coventry CV4 7AL UK. E-mail donald.singer{at}warwick.ac.uk

Background and Purpose— Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is characterized by ultrastructural abnormalities in small cerebral and systemic vessels. We assessed vasomotor function in systemic small arteries in CADASIL.

Methods— We studied 10 CADASIL patients and 10 control subjects. Resistance arteries isolated from gluteal biopsies were mounted on small-vessel myographs, and concentration responses were determined for vasoconstrictors (noradrenaline, angiotensin II, and endothelin-I) and vasodilators (acetylcholine, bradykinin, spermine-NONOate, and nifedipine). Maximum data are shown as percent potassium contraction.

Results— There was reduced potency for noradrenaline in CADASIL (CADASIL [38 arteries]: EC50, 240 nmol/L; control subjects [27 arteries]: EC50, 100 nmol/L; 2-way analysis of variance, F=9.76, P=0.002). Maximum response to angiotensin II was greater in CADASIL (120±8% versus 97±5% in control subjects; F=4.28, P=0.043). Tachyphylaxis to angiotensin II occurred in all control subjects studied but in only 3 of 9 CADASIL subjects (P=0.011, Fisher’s exact test). Vasodilation was similar in CADASIL patients compared with control subjects for endothelium-dependent dilators (acetylcholine and bradykinin) and endothelium-independent dilators (spermine-NONOate and nifedipine).

Conclusions— These results suggest a selective systemic microvascular vasoconstrictor abnormality in CADASIL in noradrenaline and angiotensin II pathways that is not explained by vasodilator impairment in endothelium or vascular smooth muscle. This could have important implications for prophylaxis and treatment of CADASIL.


Key Words: angiotensins • arteries • CADASIL • muscle, smooth • noradrenaline




This article has been cited by other articles:


Home page
StrokeHome page
A. Stenborg, H. Kalimo, M. Viitanen, A. Terent, and L. Lind
Impaired Endothelial Function of Forearm Resistance Arteries in CADASIL Patients
Stroke, October 1, 2007; 38(10): 2692 - 2697.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Rufa, M. T. Dotti, M. Franchi, M. L. Stromillo, G. Cevenini, S. Bianchi, N. De Stefano, and A. Federico
Systemic Blood Pressure Profile in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy
Stroke, December 1, 2005; 36(12): 2554 - 2558.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
T Haritunians, T Chow, R P J De Lange, J T Nichols, D Ghavimi, N Dorrani, D M St Clair, G Weinmaster, and C Schanen
Functional analysis of a recurrent missense mutation in Notch3 in CADASIL
J. Neurol. Neurosurg. Psychiatry, September 1, 2005; 76(9): 1242 - 1248.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. Dubroca, P. Lacombe, V. Domenga, J. Maciazek, B. Levy, E. Tournier-Lasserve, A. Joutel, and D. Henrion
Impaired Vascular Mechanotransduction in a Transgenic Mouse Model of CADASIL Arteriopathy
Stroke, January 1, 2005; 36(1): 113 - 117.
[Abstract] [Full Text] [PDF]